Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
20 Juni 2023 - 10:15PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leader in enabling the
development and supply of better treatments for patients worldwide,
today announced that Matti Masanovich has been named Senior Vice
President & Chief Financial Officer, effective July 5,
2023.
Prior to joining Catalent, Mr. Masanovich served as Executive
Vice President & Chief Financial Officer of Tenneco Automotive
until it was acquired by Apollo. Previously he was Chief Financial
Officer at Superior Industries International and General Cable
Corporation.
“Matti is a proven finance leader whose deep experience growing
and driving profitability at publicly traded, complex global
manufacturing companies is ideally suited to help Catalent reach
its next level of performance, including enhanced profitability and
value-creation for shareholders,” said Alessandro Maselli,
President and Chief Executive Officer of Catalent. “He brings
significant expertise and a highly strategic approach that I am
confident will make him an invaluable addition to Catalent’s
executive leadership team as we continue to seize opportunities in
the CDMO space.”
Earlier in his career, Mr. Masanovich held finance leadership
roles of increasing responsibility in a number of companies in the
automotive industry, where he demonstrated a strong history of
improvement and profitability and operating efficiency. Mr.
Masanovich began his career with PricewaterhouseCoopers LLP. He has
Bachelor of Commerce, Finance & Accounting and M.B.A. degrees
from the University of Windsor and is a Chartered Accountant in
Canada.
“Catalent is a dynamic company that operates in a critical,
fast-growing sector that has a meaningful impact on helping people
live longer, healthier lives. I am impressed with their portfolio
of solutions and feel the company has the right capabilities to
serve that market, and I am excited to work with Catalent’s
talented team to create value for its customers, patients, and
shareholders,” said Mr. Masanovich.
Mr. Masanovich will have responsibility for all aspects of
Catalent’s global financial operations, including financial
planning and analysis, controllership, public reporting and
investor relations, capital markets activities, bill payment and
collection, tax, and treasury. He will also be a member of
Catalent’s executive leadership team, the highest level of company
management.
About Catalent
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the
global leader in enabling pharma, biotech, and consumer health
partners to optimize product development, launch, and full
life-cycle supply for patients around the world. With broad and
deep scale and expertise in development sciences, delivery
technologies, and multi-modality manufacturing, Catalent is a
preferred industry partner for personalized medicines, consumer
health brand extensions, and blockbuster drugs. Catalent helps
accelerate over 1,000 partner programs and launch over 150 new
products every year. Its flexible manufacturing platforms at over
50 global sites supply around 80 billion doses of nearly 8,000
products annually. Catalent’s expert workforce of approximately
18,000 includes more than 3,000 scientists and technicians.
Headquartered in Somerset, New Jersey, the company generated nearly
$5 billion in revenue in its 2022 fiscal year. For more information
www.catalent.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements. These forward-looking statements are
based on management’s current expectations. These statements are
neither promises nor guarantees, but involve known and unknown
risks, uncertainties and other important factors that may cause
actual future events, results or achievements to be materially
different from Catalent’s expectations and projections expressed or
implied by the forward-looking statements. Important factors
include, but are not limited to, those discussed under the caption
“Risk Factors” in Catalent’s Annual Report on Form 10-K for the
year ended June 30, 2022 (as amended), Catalent’s Quarterly Report
on Form 10-Q for the three and nine months ended March 31, 2023,
and Catalent’s other filings with the SEC. Forward-looking
statements speak only as of the date of this press release and are
based on information available to Catalent as of the date of this
press release, and Catalent assumes no obligation to update such
forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230620980771/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com Media Contact: Chris Halling +44 (0)7580
041073 media@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024